000			02008 a2200565 4500
005			20250516012509.0
264		0	_c20110128
008			201101s 0 0 eng d
022			_a1423-0232
024	7		_a10.1159/000319540 _2doi
040			_aNLM _beng _cNLM
100	1		_aMotomura, Kazuyoshi
245	0	0	_aExpression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors. _h[electronic resource]
260			_bOncology _c2010
300			_a55-61 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnastrozole
650	0	4	_aAndrostadienes _xtherapeutic use
650	0	4	_aAntineoplastic Agents, Hormonal _xtherapeutic use
650	0	4	_aAromatase Inhibitors _xtherapeutic use
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aDisease-Free Survival
650	0	4	_aEstrogen Receptor alpha _xmetabolism
650	0	4	_aEstrogen Receptor beta _xmetabolism
650	0	4	_aFadrozole _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMiddle Aged
650	0	4	_aNitriles _xtherapeutic use
650	0	4	_aPhosphorylation
650	0	4	_aPredictive Value of Tests
650	0	4	_aPrognosis
650	0	4	_aRetrospective Studies
650	0	4	_aSerine _xmetabolism
650	0	4	_aTamoxifen _xtherapeutic use
650	0	4	_aTriazoles _xtherapeutic use
700	1		_aIshitobi, Makoto
700	1		_aKomoike, Yoshifumi
700	1		_aKoyama, Hiroki
700	1		_aNagase, Hideki
700	1		_aInaji, Hideo
700	1		_aNoguchi, Shinzaburo
773	0		_tOncology _gvol. 79 _gno. 1-2 _gp. 55-61
856	4	0	_uhttps://doi.org/10.1159/000319540 _zAvailable from publisher's website
999			_c20369755 _d20369755